| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |